Table 2.
The associations between CVH score and CVD-related biomarkers
| Total, n=5379 | |||||||
| hsCRP (mg/L) |
D-dimer (μg/mL) |
Fibrinogen (mg/dL) |
Homocysteine (μmol/L) |
hs-cTnT (ng/L) |
NT-ProBNP (pg/mL) |
IL-6* (pg/mL) |
|
| Model 1 | −0.16
(−0.17,−0.14) |
−0.06
(−0.07,−0.05) |
−0.02
(−0.03,−0.02) |
−0.02
(−0.02,−0.01) |
−0.05
(−0.06,−0.05) |
0.00004 (−0.01, 0.01) |
−0.09
(−0.10,−0.08) |
| Model 2 | −0.13
(−0.14,− 0.12) |
−0.03
(−0.04,−0.02) |
−0.02
(−0.02,−0.02) |
−0.01
(−0.01,−0.01) |
−0.04
(−0.05,−0.03) |
0.02
(0.01,0.03) |
−0.07
(−0.08,−0.06) |
| Women, n=2775 | |||||||
| Model 1 | −0.18
(−0.20,−0.16) |
−0.07
(−0.09,−0.06) |
−0.03
(−0.03,−0.03) |
−0.02
(−0.03,−0.02) |
−0.04
(−0.05,− 0.04) |
0.01 (−0.01,0.03) |
−0.11
(−0.12,−0.10) |
| Model 2 | −0.16
(−0.18,−0.14) |
−0.03
(−0.05,−0.02) |
−0.02
(−0.03,−0.02) |
−0.01
(−0.02,−0.01) |
−0.03
(−0.04,−0.02) |
0.03
(0.01,0.04) |
−0.08
(−0.09,−0.07) |
| Men, n=2604 | |||||||
| Model 1 | −0.13
(−0.15,−0.11) |
−0.04
(−0.05,−0.02) |
−0.02
(−0.02,−0.02) |
−0.01
(−0.02,−0.01) |
−0.07
(−0.08,−0.06) |
−0.01 (−0.03, 0.01) |
−0.07
(−0.08,−0.06) |
| Model 2 | −0.10
(−0.12,−0.08) |
−0.02
(−0.03,−0.001) |
−0.02
(−0.02,−0.01) |
−0.01
(−0.01,−0.004) |
−0.06
(−0.07,−0.05) |
0.005 (−0.01, 0.02) |
−0.05
(−0.06,−0.04) |
*For IL-6, total sample size = 5279; women, n = 2733; men, n = 2546.
CVD, cardiovascular disease;CVH, cardiovascular health; hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T; IL-6, interleukin 6; NT-proBNP, N-terminal pro B-type natriuretic peptide.